Quick Answer
Innate Pharma SA reported Total Assets of $111.06 million for fiscal year 2024.
Innate Pharma SA Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $111.06M | -36.6% |
| 2023 | $175.19M | -12.1% |
| 2022 | $199.29M | -25.5% |
| 2021 | $267.50M | -13.0% |
| 2020 | $307.42M | -23.4% |
| 2019 | $401.36M | -11.0% |
| 2018 | $451.22M | +76.9% |
| 2017 | $255.02M | — |
- Innate Pharma SA showed a decrease of -36.6% in Total Assets compared to the prior fiscal year.
- Over the 2017–2024 period, Innate Pharma SA’s total assets has declined by 56.5% (from $255.02 million to $111.06 million).
- The most recent figure is from Innate Pharma SA’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: